C
Corvus Pharmaceuticals, Inc. (CRVS)
NGM – Real vaqt narxi. Valyuta: USD
13.49
+0.44 (3.37%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
13.26
-0.23 (-1.67%)
Bozordan keyin: Jun 26, 2026, 6:30 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
13.49
+0.44 (3.37%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
13.26
-0.23 (-1.67%)
Bozordan keyin: Jun 26, 2026, 6:30 PM EDT
This stock has a consensus price target of $28.86 based on the ratings of 8 analysts. The high is $42.00 and the low is $11.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 11 | $ 28.86 | $ 42 |
| O’zgarish | -15.71% | 121.15% | 221.84% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-17 | 196.52% | Goldman Sachs | $40 | Initiates Coverage On | Buy |
| 2026-03-13 | 144.63% | Oppenheimer | $32 → $33 | Reiterates | Outperform |
| 2026-01-22 | 211.34% | Jefferies | $13 → $42 | Maintains | Buy |
| 2026-01-21 | 137.21% | Oppenheimer | $15 → $32 | Maintains | Outperform |
| 2026-01-21 | 107.56% | Barclays | $16 → $28 | Maintains | Overweight |